Bruno Hernaez De La Plaza

Title: Bruno Hernaez De La Plaza: Innovator in Antiviral Peptides

Introduction

Bruno Hernaez De La Plaza is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of antiviral therapies, particularly through his innovative work on peptides that target viral infections.

Latest Patents

Bruno holds a patent for "Antiviral peptides from African swine fever virus which prevent the binding of the virus to DLC8." This invention provides a new antiviral therapy that inhibits viral infections produced by viruses utilizing the dynein-based intracellular transport machinery. The therapy works by preventing the interaction between the viral protein and the cellular DLC8 protein. This groundbreaking approach discloses for the first time the blocking of this interaction through peptides that comprise or consist of the totality or a partial sequence of the viral protein corresponding to the binding domain with DLC8. He has 1 patent to his name.

Career Highlights

Throughout his career, Bruno has worked with various organizations, including Alternative Gene Expression, S.L. (Algenex) and the Instituto Nacional De Investigación y Tecnología Agraria y Alimentaria. His work has focused on developing innovative solutions to combat viral infections, showcasing his dedication to advancing medical science.

Collaborations

Bruno has collaborated with notable colleagues such as Covadonga Alonso Martí and José Angel Martinez Escribano. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Bruno Hernaez De La Plaza is a pioneering inventor whose work on antiviral peptides represents a significant advancement in the fight against viral infections. His innovative approach and dedication to research continue to inspire advancements in medical therapies.